A review of intranasal ketorolac tromethamine for the short-term management of moderate to moderately severe pain that requires analgesia at the opioid level

References

• Pain: Current Understanding of Assessment, Management, and Treatments. Editoral advisory board Berry PH, Chapman CR, Covington EC, Dahl JL, Katz JA, Miakowski C. Continuing Education Sponsored by the American Pain Society and supported by unrestricted education grant from the National Pharmaceutical Council, Inc., Dec 2001
   Google Scholar
• SPRIX (ketorolac tromethamine) Nasal Spray [package insert]. Shirley, NY: Regency Therapeutics, 2011
   Google Scholar
• Boyer KC, McDonald P, Zoetis T. A novel formulation of ketorolac tromethamine for intranasal administration: preclinical safety evaluation. Int J Toxicol 2010;29:467-78
   PubMed Web of Science ®Google Scholar
• Food and Drug Administration. Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations. 32th ed. Silver Spring, MD; Food and Drug Administration, 2012. http://www.accessdata.fda.gov/scripts/cder/ob/eclink.cfm. Accessed January 2012
   Google Scholar
• Strom BL, Berlin JA, Kinman JL, et al. Parenteral ketorolac and risk of gastrointestinal and operative site bleeding. JAMA 1996;275:376-82
   PubMed Web of Science ®Google Scholar
• Gillis JC, Brogden RN. Ketorolac. A reappraisal of its pharmacodynamic and pharmacokinetics properties and therapeutic use in pain management. Drugs 1997;53:139-88
   PubMed Web of Science ®Google Scholar
• Brown CR, Mazzulla JP, Mok MS, et al. Comparison of repeat doses of intramuscular ketorolac tromethamine and morphine sulfate for analgesia after major surgery. Pharmacotherapy 1990;10:45-50S
   Web of Science ®Google Scholar
• Newberg AB, Hersh EV, Levin LM, et al. Double-blind, placebo-controlled, randomized pilot study of cerebral blood flow patterns employing SPECT imaging in dental postsurgical pain patients with and without pain relief. Clin Ther 2011;33:1894-903
   PubMed Web of Science ®Google Scholar
• TORADOL (ketorolac tromethamine) tablet, film coated [package insert]. Nutley, NJ: Roche Laboratories Inc., Dec 2008
   Google Scholar
• Chen JY, Ko TL, Wen YR, et al. Opioid-sparing effects of ketorolac and its correlation with the recovery of postoperative bowel function in colorectal surgery patients: a prospective randomized double-blinded study. Clin J Pain 2009;25:485-9
   PubMed Web of Science ®Google Scholar
• Pavy TJ, Paech MJ, Evans SF. The effect of intravenous ketorolac on opioid requirement and pain after cesarean delivery. Anesth Analg 2001;92:1010-14
   PubMed Web of Science ®Google Scholar
• Etches RC, Warriner CB, Badner N, et al. Continuous intravenous administration of ketorolac reduces pain and morphine consumption after total hip or knee arthroplasty. Anesth Analg 1995;81:1175-80
   PubMed Web of Science ®Google Scholar
• McNicol E, Horowicz-Mehler N, Fisk RA, et al. Management of opioid side effects in cancer-related and chronic noncancer pain: a systematic review. J Pain 2003;4:231-56
   PubMed Web of Science ®Google Scholar
• White PF. The role of non-opioid analgesic techniques in the management of pain after ambulatory surgery. Anesth Analg 2002;94:577-85
   PubMed Web of Science ®Google Scholar
• McAleer SD, Majid O, Venables E, et al. Pharmacokinetics and safety of ketorolac following single intranasal and intramuscular administration in healthy volunteers. J Clin Pharmacol 2007;47:13-18
   PubMed Web of Science ®Google Scholar
• Hersh EV, Lally ET, Moore PA. Update on cyclooxygenase inhibitors: has a third COX isoform entered the fray? Curr Med Res Opin 2005;21:1217-26
   PubMed Web of Science ®Google Scholar
• Dray A. Inflammatory mediators of pain. Br J Anaesth 1995;75:125-31
   PubMed Web of Science ®Google Scholar
• Ferreira SH, Moncada S, Vane JR. Prostaglandins and the mechanism of analgesia produced by aspirin-like drugs. Br J Pharmacol 1973;49:86-97
   PubMed Web of Science ®Google Scholar
• Moodie JE, Brown CR, Bisley EJ, et al. The safety and analgesic efficacy of intranasal ketorolac in patients with postoperative pain. Anesth Analg 2008;107:2025-31
   PubMed Web of Science ®Google Scholar
• Brown C, Moodie J, Bisley E, et al. Intranasal ketorolac for postoperative pain: a phase 3, double-blind, randomized study. Pain Med 2009;10:1106-14
   PubMed Web of Science ®Google Scholar
• Grant GM, Mehlisch DR. Intranasal ketorolac for pain secondary to third molar impaction surgery: a randomized, double-blind, placebo-controlled trial. J Oral Maxillofac Surg 2010;68:1025-31
   PubMed Web of Science ®Google Scholar
• Singla N, Singla S, Minkowitz HS, et al. Intranasal ketorolac for acute postoperative pain. Curr Med Res Opin 2010;26:1915-23
   PubMed Web of Science ®Google Scholar
• Warner TD, Guiliano F, Vojnovic I, et al. Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis. Proc Natl Acad Sci USA 1999;96:7563-8
   PubMed Web of Science ®Google Scholar
• Ketorolac tromethamine injection, solution [package insert]. Lake Forest, IL: Hospira, Inc., Mar 2007
   Google Scholar